Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Metformin/Rosiglitazone Tied to Early Decrease in Diabetes
But subsequent deterioration in insulin resistance and β-cell function similar to placebo
This article is older than one year and is no longer available.

Copyright © 2011 HealthDay. All rights reserved.

September 30, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

'Just-in-Time' Methodology Can Reduce Patient Waiting Times

AMA Launches Three Programs for Physician Wellness

Pharmacists Less Happy at Work Versus Other Occupations

ESMO: Drug Gives Survival Boost in HER2+ Breast Cancer

AACR: Obese in Adolescence, Colon Cancer in Later Life?

ACC Withdraws One Choosing Wisely Recommendation